Preclinical Studies in Support of Defibrotide for the Treatment of Multiple Myeloma and Other Neoplasias

PURPOSE OF THE STUDY: Defibrotide (DF), an orally bioavailable polydisperse oligonucleotide has promising activity in hepatic veno-occlusive disease (VOD), a stem cell transplantation-related toxicity, characterized by microangiopathy. The anti-thrombotic properties of DF and its minimal hemorrhagic...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Cancer Res
Autors principals: Mitsiades, Constantine S., Rouleau, Cecile, Echart, Cinara, Menon, Krishna, Teicher, Beverly, Distaso, Maria, Palumbo, Antonio, Boccadoro, Mario, Anderson, Kenneth C., Iacobelli, Massimo, Richardson, Paul G.
Format: Artigo
Idioma:Inglês
Publicat: 2009
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4401498/
https://ncbi.nlm.nih.gov/pubmed/19228727
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-08-1270
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars